🇺🇸 FDA

Company profile · Sponsor

Helsinn

Helsinn Birex Pharmaceuticals Ltd

EAB2751 · EMA pharma GB
Pipeline
1
Drugs
0
Patents
0

Quick answer

Helsinn (EAB2751) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EAB2751
Exchange EMA
Company type pharma
Headquarters GB

Pipeline (1)

Search pipeline →

  1. IVEMEND 150 mg powder for solution for infusion, fosnetupitant chloride 260 mg/palonosetron 1.5 mg, fosnetupitant chloride 260 mg/palonosetron 2.5 mg, Ondansetrone Hikma 8 mg/4 ml Soluzione iniettabile, Sodium Chloride Injection BP 0.9% w/v

    Helsinn

    Chemotherapy-induced nausea and vomiting

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Helsinn?

Helsinn (EAB2751) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Helsinn sponsor?

We track 1 ClinicalTrials.gov-linked program for Helsinn, including IVEMEND 150 mg powder for solution for infusion, fosnetupitant chloride 260 mg/palonosetron 1.5 mg, fosnetupitant chloride 260 mg/palonosetron 2.5 mg, Ondansetrone Hikma 8 mg/4 ml Soluzione iniettabile, Sodium Chloride Injection BP 0.9% w/v. Open each program for phase, modality, NCT IDs, and indication details.

Where does Helsinn company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.